D
Deep Blue Retina Clinical Research | Southaven, MS
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
UBX1325
BI 764524
Foselutoclax
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
Locations recently updated
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join...
Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only
The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Ed...
Active, not recruiting
Edema
Diabetic Macular Edema
Drug: foselutoclax
Drug: Aflibercept
Trial sponsors
N
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems